Obermayer (Pennsylvania): The Race to Create a COVID-19 Vaccine: Acceleration and Collaboration

From the very outset of the COVID-19 pandemic the development of an effective and safe vaccine for COVID-19 became a public and private priority pursed with urgency and intensity. Towards that end, the United States government and federal agencies are collaborating with private biopharmaceutical companies to accelerate the vaccine development. This article will briefly summarize the following: (1) regulatory efforts to accelerate vaccine development, (2) the various collaborations established to develop a vaccine, and (3) the current state of the most promising—and government funded—clinical trials. MORE.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Related Posts

Categories

Categories